Background: Patients with anti–melanoma differentiation–associated gene 5 (MDA5) antibody–positive dermatomyositis (DM) frequently develop rapidly progressive interstitial lung disease and may also ...
Annexon offers high-risk, high-reward potential with its C1q-targeted pipeline, led by tanruprubart for GBS and vonaprument for geographic atrophy. Tanruprubart’s Phase III results are promising, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results